EUVIMEDEUVIMED entdecken
Klinische Studie

Feasibility of Using Continuous Glucose Monitoring to Detect Glycemic Abnormalities in Children with Cystic Fibrosis

Amanda Leonard, Isabel R Judware, Lori L Vanscoy, Shruti M Paranjape, Donna Peeler, Malinda Wu, Scott M Blackman, Peter J Mogayzel

Hormone Research in Paediatrics · 27.11.2024 · 99 (3) · 385-390

DOI: 10.1159/000542786 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 27.11.2024. Verfasst von Amanda Leonard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Nutrition, Johns Hopkins Hospital, Baltimore, Maryland, USA, amleonar@jhmi.edu. Hauptthemen laut MEDLINE: Cystic Fibrosis, Blood Glucose, Blood Glucose Self-Monitoring, Diabetes Mellitus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cystic fibrosis-related diabetes (CFRD) is linked to worsening pulmonary function and increased mortality in people with cystic fibrosis (CF). Because of this correlation, early recognition of CFRD is important. Current recommendations for detecting glucose abnormalities using an oral glucose tolerance test (OGTT) can be difficult to achieve in a busy clinical setting.

Methods

We trialed a 10-day continuous glucose monitoring (CGM) (Dexcom G6Pro) session in patients seen in our pediatric CF clinic that could not do an OGTT (reasons include emesis with OGTT or fear of needles) or that had an abnormal OGTT (to gather additional data to make treatment decisions).

Results

Of the 36 sensors placed, 34 (94%) were returned. Devices were worn for a median of 10 days (range 4–10 days). Of the 34 CGMs returned, 20 (59%) met the criterion for referral to a pediatric endocrinologist.

Conclusion

CGM placement is feasible in a busy CF clinic to detect glucose abnormalities in children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisBlood GlucoseBlood Glucose Self-MonitoringDiabetes MellitusHumansChildMaleFemaleAdolescentFeasibility StudiesChild, PreschoolGlucose Tolerance TestContinuous Glucose Monitoring

Stichwörter der Autor:innen

Continuous glucose monitoringDiabetesHyperglycemiaOral glucose tolerance testing

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Division of Pediatric Nutrition, Johns Hopkins Hospital, Baltimore, Maryland, USA, amleonar@jhmi.edu.
  • Division of Pediatric Nutrition, Johns Hopkins Hospital, Baltimore, Maryland, USA.
  • Eudowood Division of Pediatric Respiratory Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
  • Division of Pediatric Endocrinology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Zitieren

APA

Leonard, A., Judware, I. R., Vanscoy, L. L., Paranjape, S. M., Peeler, D., Wu, M., Blackman, S. M., & Mogayzel, P. J. (2024). Feasibility of Using Continuous Glucose Monitoring to Detect Glycemic Abnormalities in Children with Cystic Fibrosis. Hormone Research in Paediatrics, 99(3), 385-390. https://doi.org/10.1159/000542786

Vancouver

Leonard A, Judware IR, Vanscoy LL, Paranjape SM, Peeler D, Wu M, et al. Feasibility of Using Continuous Glucose Monitoring to Detect Glycemic Abnormalities in Children with Cystic Fibrosis. Hormone Research in Paediatrics. 2024;99(3):385-390. doi:10.1159/000542786

BibTeX
@article{Leonard2024,
  author = {Leonard, Amanda and Judware, Isabel R and Vanscoy, Lori L and Paranjape, Shruti M and Peeler, Donna and Wu, Malinda and Blackman, Scott M and Mogayzel, Peter J},
  title = {Feasibility of Using Continuous Glucose Monitoring to Detect Glycemic Abnormalities in Children with Cystic Fibrosis},
  journal = {Hormone Research in Paediatrics},
  year = {2024},
  volume = {99},
  number = {3},
  pages = {385--390},
  doi = {10.1159/000542786}
}
Kostenlos starten →